Junaston 10mg Tablet contains Dydrogesterone 10mg, an oral progestogen used on prescription where progesterone support is clinically required.

This content focuses on infertility due to luteal phase insufficiency, recurrent pregnancy loss, and luteal phase defects.

Dydrogesterone acts on progesterone receptors and helps prepare and maintain the endometrium, the uterine lining needed for implantation and early pregnancy support.

Because it is taken orally, it may be convenient for women who need luteal support under the supervision of a fertility specialist or gynecologist.

The luteal phase is the post-ovulation part of the menstrual cycle, when progesterone helps convert the endometrium into a receptive lining.

A luteal phase defect refers to inadequate progesterone effect or a short/insufficient luteal phase, which may affect implantation or early pregnancy maintenance.

In selected patients, dydrogesterone may be prescribed after ovulation, insemination, or embryo transfer to supplement luteal progesterone activity.

The goal is to support secretory endometrial transformation, implantation conditions, and early gestational support when the treating doctor identifies a need.

Recurrent pregnancy loss can have many causes, including genetic, anatomical, endocrine, immune, and unexplained factors. Progesterone support may be considered when luteal insufficiency or early pregnancy support is part of the clinical plan.

Junaston should be used only after medical evaluation and only for the dose and duration advised by the physician.

The timing depends on the indication. In fertility treatment, progestogen support is commonly aligned with ovulation, insemination, oocyte retrieval, or embryo transfer protocols.

Do not self-start or stop Junaston during fertility treatment or pregnancy. Follow the exact prescription schedule.

• Women with unexplained vaginal bleeding.
• Patients with known allergy to dydrogesterone or tablet excipients.
• Patients with liver disease, hormone-sensitive conditions, or complex pregnancy history unless cleared by a doctor.
• Anyone taking other hormonal medicines without medical review.

Junaston 10mg is a prescription medicine. It is not a general fertility booster and should be used only for diagnosed progesterone-support needs.

Report severe abdominal pain, heavy bleeding, allergic symptoms, jaundice, or unusual symptoms to a healthcare professional promptly.

Yes, dydrogesterone may be prescribed for luteal phase support when a doctor wants to supplement progesterone activity after ovulation or assisted reproduction treatment.

The exact start day and duration should match the treatment plan, because natural cycles, IUI cycles, and IVF cycles may be managed differently.

Progesterone activity helps the estrogen-primed endometrium become secretory and receptive. Dydrogesterone is used to support this progesterone effect in selected patients.

Endometrial receptivity depends on several factors, so Junaston should be part of a complete fertility evaluation rather than a standalone solution.

Some clinicians prescribe luteal support after intrauterine insemination, especially when ovulation induction medicines are used or luteal insufficiency is suspected.

Patients should follow the dose and stop date given by their fertility specialist.

Dydrogesterone is one oral option used in luteal support protocols after IVF or embryo transfer. It supports progesterone receptor activity during the implantation window.

The fertility clinic will decide whether oral dydrogesterone, vaginal progesterone, injections, or a combination is appropriate.

At commonly used clinical doses, dydrogesterone is generally described as a progestogen that does not suppress ovulation in the way contraceptive progestins are intended to do.

Timing still matters, so it should be taken only on the schedule prescribed for the cycle.

Junaston cannot prevent every miscarriage because recurrent pregnancy loss may have chromosomal, anatomical, endocrine, immune, clotting, or unexplained causes.

It may be included in early pregnancy support when progesterone support is clinically indicated by the treating doctor.

Duration varies by the reason for treatment, previous pregnancy history, ultrasound findings, and the clinic protocol.

Do not stop Junaston suddenly after a positive pregnancy test unless the prescribing doctor confirms the plan.

Possible clues can include a short luteal phase, premenstrual spotting, difficulty sustaining early pregnancy, or specific hormone findings, but symptoms alone are not diagnostic.

A gynecologist may use cycle history, ovulation tracking, ultrasound, and blood tests to decide whether luteal support is needed.

Folic acid and prenatal supplements are commonly used during fertility planning, but all medicines and supplements should be disclosed to the doctor.

This helps avoid duplication, interactions, and confusion during assisted reproduction or early pregnancy care.

Some patients may experience nausea, headache, breast tenderness, bloating, spotting, or menstrual changes.

Seek medical advice promptly for heavy bleeding, severe pain, allergic symptoms, yellowing of the eyes or skin, or any symptom that feels unusual or concerning.